Skip to the page

Data / Drug companies / Weeks & Leo Co., Inc.

Weeks & Leo Co., Inc.: 16 products in the FDA NDC directory, labeler code 11383

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Weeks & Leo Co., Inc. (labeler code 11383) lists 16 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 16 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 6, 2026.

The request: Watch Weeks & Leo Co., Inc. (FDA labeler code 11383): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
11383
Products in commercial distribution
16
Packages
28
Finished drugs by generic name
8
Prescription products
0
Over the counter products
16
Flagged as original packager
15 of 15 products that carry the flag
Started marketing in the last 12 months
1
Earliest marketing start
October 28, 2010
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs16100%

Products by type

TypeProductsShare
Over the counter drugs16100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Piperonyl butoxide, pyrethrum extract522
Lidocaine 5%323
Alcohol2293
Hydrocortisone2171
Camphor (synthetic)112
Dextromethorphan hbr, guaifenesin167
Diphenhydramine hydrochloride, pramoxine hydrochloride11
Hydrocortisone 1%115

Dosage forms

Dosage formProductsShare
Cream531.2%
Shampoo425%
Gel212.5%
Kit16.2%
Liquid16.2%
Syrup16.2%
Lotion16.2%
Ointment16.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Oxify11383-331CreamOver the counter monograph drugsOctober 6, 2026
Oxify11383-003CreamOver the counter monograph drugsOctober 31, 2025
Oxify11383-002CreamOver the counter monograph drugsOctober 31, 2025
Lice No More Lice Killing11383-001ShampooOver the counter monograph drugsJuly 1, 2025
Hydrocortisone11383-268OintmentOver the counter monograph drugsOctober 1, 2023
Anti-itch Paraben Free11383-313CreamOver the counter monograph drugsMarch 3, 2023
Carolina Crud Crusher11383-311SyrupOver the counter monograph drugsJune 1, 2022
Lice Killing11383-310ShampooOver the counter monograph drugsMay 17, 2021
AntiochPharma Rapidgel Hand Sanitizer11383-309GelOver the counter monograph drugsMarch 24, 2020
AntiochPharma Hand Sanitizer11383-308GelOver the counter monograph drugsMarch 24, 2020
Bite and Itch11383-192LotionOver the counter monograph drugsJune 15, 2015
Anti itch11383-292CreamOver the counter monograph drugsFebruary 10, 2013
ABC Lice Killing11383-312ShampooOver the counter monograph drugsJune 18, 2012
Weeks and Leo Medicated Vaporizing Steam11383-256LiquidOver the counter monograph drugsNovember 2, 2011
Lice Killing11383-253ShampooOver the counter monograph drugsMarch 25, 2011
Weeks and Leo Complete Lice Treatment11383-255KitOver the counter monograph drugsOctober 28, 2010

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.